Use of beta.sub.2 antagonists in the treatment of inflammatory d

Details Use of beta.sub.2 antagonists in the treatment of inflammatory d Use of beta.sub.2 antagonists in the treatment of inflammatory d

1988-06-06

1990-03-13

Friedman, Stanley J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Nitrogen containing other than solely as a nitrogen in an...

A61K 31135

Patent

active

049083872

ABSTRACT:
A method of treating inflammation and joint deterioration in mammals which comprises administering a therapeutically effective amount of a selective beta.sub.2 adrenergic receptor antagonist. The method is particularly useful for the treatment of rheumatoid arthritis in humans.

REFERENCES:
Chem. Abst., vol. 102 (1985)-197713p.
Vyden et al., "The Effect of Propranolol on Peripheral Hemodynamics in Rheumatoid Arthritis," Arthritis and Rheumatism (1971) 14:420.
Levine et al., "Contribution of Sensory Afferents and Sympathetic Efferents to Joint Injury in Experimental Arthritis," J. Neurosci. (1986) 6:3423-3429.
Levine et al., "Clinical Response to Regional Intravenous Guanethidine in Patients with Rheumatoid Arthritis," J. Rheumatol. (1986) 13:1040-1043.
Kaplan et al., "Propranolol and the Treatment of Rheumatoid Arthritis," Arthritis and Rheumatism (1980) 23:253-255.
Levine et al., "Hypothesis: The Nervous System May Contribute to the Pathophysiology of Rheumatoid Arthritis," J. Rheumatol. (1985) 12:406-411.
"A Comprehensive Report on the Pharmacology and Toxicology of Butoxamine (B.W. 64-9)," Burroughs Wellcome & Co. (1965).
"A Supplementary Report on the Pharmacology and Toxicology of Butoxamine (B.W. 64-9)," Burroughs Wellcome & Co. (1966).

Affiliated with

Also associated with

Rating

Use of beta.sub.2 antagonists in the treatment of inflammatory d does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of beta.sub.2 antagonists in the treatment of inflammatory d, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of beta.sub.2 antagonists in the treatment of inflammatory d will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-51488